Gastro Chronicles                         February  2012    
                                                                                                                                                                                                                                                                                  
                                                                                                  

Srinivas Seela, MD,  Harinath Sheela, MD & Seela Ramesh, MD
 
    Fellowship Training:Yale University School of Medicine
 
                                            Virginia Commonwealth University
  

Announcement

Digestive and Liver Center of Florida

We are pleased to announce that the Endo-Surgical Center of Florida is now open to serve our Central Florida Community.

The Endo-Surgical Center of Florida is an outpatient surgery center dedicated

to providing the highest quality surgery services. 

100 North Dean Rd.

Suite 102

Orlando, FL 32825

407-506-0006

Dr. Seela, Sheela and Ramesh 
Services now available :

Vaccinations:
Hepatitis A & B

Nutritional Counseling

Blood Draws

Saturday Appointments

 

Our Locations: 
  
100 N. Dean Road, Suite 101
Orlando, FL 32825.

3000 N. Orange Ave., Suite C
Orlando, FL 32804   
 

125 W. Pineview Street

Suite 1001

Altamonte Springs, FL 32714

 

 

407-384-7388 

  
In This Issue
Endo-Surgical Center is Now Open!
Hepatitis Support Group and Patient Appreciation Dates
Nutrition Article on Fiber from our Registered Dietitian
Main Article: Esophageal Cancer
Our next Hepatitis Support Meeting is:
Monday, 02/27
 Time: 5:30pm
Come and learn valuable information to take better care of yourself or your family members! 
 
Our next Patient Appreciation 
Breakfast is:
Tuesday, 04/10
Time: 8:30am-10:30am
  
Please R.S.V.P. with our office at  407-384-7388. 

 Physicians

We now have a Registered Dietitian Available for consultations
in our office! 
Fiber

Nutrition Tip: Fiber in Your Diet. Click here to learn how to check the Nutrition Facts Panel on food labels to find out how much fiber you are getting!
Quick Links
Follow Us on Twitter: 
 
Follow us on Twitter

Become Our Fan on Facebook:  
 
 Find us on Facebook

View our You Tube:

YouTube Logo

Join Our List  

Join Our Mailing List   

 

ESOPHAGEAL CANCER AND CLINICAL FEATURES

Gastrointestinal tract is the second most common noncutaneous site for cancer and the second major cancer related mortality in the USA. Esophageal cancer is a cancerous (malignant) tumor of the esophagus, the muscular tube that moves food from the mouth to the stomach.

   

Esophageal cancer usually begins in the cells that line the inside of the esophagus. Esophageal cancer can occur anywhere along the esophagus, but in people in the United States, it occurs most often in the lower portion of the esophagus.

 

More men than women get esophageal cancer. It's not clear what causes esophageal cancer. Esophageal cancer occurs when cells in your esophagus develop errors (mutations) in their DNA. The errors make cells grow and divide out of control.

The accumulating abnormal cells form a tumor in the esophagus that can grow to invade nearby structures and spread to other parts of the body.

Esophageal cancer isn't common in the United States. In other areas of the world, such as Asia and parts of Africa, esophageal cancer is much more common.

 
Digestive System
ESOPHAGEAL CANCER: INCIDENCE AND ETIOLOGY

Cancer of esophagus is relatively uncommon but extremely lethal malignancy. The diagnosis was made in 16,980 Americans in 2011 and led to 14,710 deaths.In North America and Western Europe, the disease is more common in blacks than whites and in males than females. It appears most often after age 50 and seems to be associated with a lower socioeconomic status.

Some Etiologic Factors believed to be associated with esophageal cancer

  1. Excess alcohol consumption
  2. Cigarette smoking
  3. Having bile reflux
  4. Chewing tobacco
  5. Having difficulty swallowing because of an esophageal   sphincter that won't relax (achalasia)
  6. Drinking very hot liquids
  7. Eating few fruits and vegetables
  8. Eating foods preserved in lye, such as lutefisk, a Nordic recipe  made from whitefish, and some olive recipes
  9. Having gastroesophageal reflux disease (GERD)
  10. Being obese
  11. Having precancerous changes in the cells of the esophagus (Barrett's esophagus)
  12. Undergoing radiation treatment to the chest or upper abdomen
  13. Other ingested carcinogens: Nitrates converted to nitrites , smoked opiates, fungal toxins in pickled vegetables
  14. Host susceptibility : Esophageal web with glossitis and iron deficiency (Plummer-Vinson or Paterson-Kelly syndrome), congenital hyperkeratosis and pitting of the palms and soles

■            Gastroesophageal reflux disease  (GERD) and its resultant

 Barrett's esophagus increase esophageal cancer risk due to the chronic irritation of the mucosal lining. Adenocarcinoma is more common in this condition.  

■            Human papillomavirus (HPV) 

 

 Barretts Esophagus

Barrett's esophagus is considered to be a risk factor for esophageal adenocarcinoma

          

ESOPHAGEAL CANCER: TYPES OF CANCERS
Two types of esophageal cancer are squamous cell carcinoma (cancer that begins in flat cells lining the esophagus) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Adenocarcinomas are often associated with a history of  gastroesophageal reflux disease and Barrett's esophagus. A general rule of thumb is that a cancer in the upper two-thirds is a squamous cell carcinoma and one in the lower one-third is an adenocarcinoma.  

Other rare types: rare forms of esophageal cancer include choriocarcinoma, lymphoma, melanoma, sarcoma and small cell cancer.

 

 ESOPHAGEAL CANCER: CLINICAL FEATURES

About 10% of esophageal cancers occur in the upper third of the esophagus, 35% in the middle third and 55% in the lower third. In the lower third squamous cell carcinomas and adenocarcinomas cannot be distinguished radiologically or endoscopically.

Dysphagia (difficulty swallowing) and odynophagia (painful swallowing) are the most common symptoms of esophageal cancer.  

Dysphagia is the first symptom in most patients. Odynophagia may also be present. Fluids and soft foods are usually tolerated, while hard or bulky substances (such as bread or meat) cause much more difficulty. Substantial weight loss is characteristic as a result of reduced appetite and poor nutrition and the active cancer. Pain behind the sternum or in the epigastrium, often of a burning, heartburn-like nature, may be severe, present itself almost daily, and is worsened by swallowing any form of food. Another sign may be an unusually husky, raspy, or hoarse sounding cough, a result of the tumor affecting the recurrent laryngeal nerve.The presence of the tumor may disrupt normal peristalsis (the organized swallowing reflex), leading to nausea and vomiting, regurgitation of food, coughing and an increased risk of aspiration pneumonia. The tumor surface may be fragile and bleed, causing hematemesis (vomiting up blood). Compression of local structures occurs in advanced disease, leading to such problems as upper airway obstruction and superior vena cava syndrome. Fistulas may develop between the esophagus and the trachea, increasing the pneumonia risk; this condition is usually heralded by cough, fever or aspiration. Most of the people diagnosed with esophageal cancer have late-stage disease. This is because people usually do not have significant symptoms until half of the inside of the esophagus, called the lumen, is obstructed, by which point the tumor is fairly large.If the disease has spread elsewhere, this may lead to symptoms related to this:liver metastasis could cause jaundice and ascites, lung metastasis could cause shortness of breath , pleural effusions, etc.

Attempts at endoscopic and cytologic screening for carcinoma in patients with Barrett's esophagus, while effective as a means of detecting high-grade dysplasia, have not yet been shown to improve the prognosis in the individuals found to have carcinoma. Routine contrast radiographs effectively identify esophageal lesions large enough to cause symptoms
ESOPHAGEAL CANCER: DIAGNOSIS

The diagnosis is best made with esophagogastroduodenoscopy (EGD, endoscopy). Biopsies taken of suspicious lesions are then examined histologically for signs of malignancy.  

 

Additional testing is usually performed to estimate the tumor stage. Computed tomography (CT) of the chest, abdomen and pelvis, can evaluate whether the cancer has spread to adjacent tissues or distant organs (especially liver and lymph nodes). The sensitivity of CT scan is limited by its ability to detect masses (e.g. enlarged lymph nodes or involved organs) generally larger than 1 cm. FDG-PET (positron emission tomography) scan is also being used to estimate whether enlarged masses are metabolically active, indicating faster-growing cells that might be expected in cancer. Esophageal endoscopic ultrasound (EUS) can provide staging information regarding the level of tumor invasion, and possible spread to regional lymph nodes.